RPRX
vs
LLY
RPRX
LLY
Over the past 12 months, RPRX has significantly outperformed LLY, delivering a return of +49% compared to the LLY's +6% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
RPRX
LLY
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Multiples-Based Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
Royalty Pharma PLC
NASDAQ:RPRX
|
46.35
USD
|
|||||
|
Eli Lilly and Co
NYSE:LLY
|
878.24
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
RPRX, LLY
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
Royalty Pharma PLC
Revenue
|
|||||||||||
|
Eli Lilly and Co
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
RPRX, LLY
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
Royalty Pharma PLC
NASDAQ:RPRX
|
|||||||||
|
Eli Lilly and Co
NYSE:LLY
|
|||||||||
Compare company's free cash flow with its competitors.
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
RPRX, LLY
Performance Gap
RPRX, LLY
Performance By Year
RPRX, LLY
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
| US |
|
Eli Lilly and Co
NYSE:LLY
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|